The Oncological Sensibility Blood Test is one of the greatest advances in targeted oncologic therapy.
In most cases, cancer treatment follows established protocols without really knowing if the treatment will be effective because it is not known if the person’s tumor cells will be sensitive to the treatments. The test lets you know exactly which products will be most effective without having to guess or experiment with various treatments to find what works.
The RGCC test begins with a simple blood sample. That sample is then sent to an international lab where the Circulating Tumor Cells (CTC) are isolated and tested to determine their sensitivities. The results are normally ready in 7 days, at which time a treatment plan is formulated that is unique to the patient and the cancer. A plan that uses the best possible substances, whether natural or chemical to fight the tumor and restore health.
There are 3 main tests:
- The Quantification of Circulating Tumor Cells (CTC)
- The tumor’s sensitivity to 53 common Chemotherapy Drugs
- The genetic make-up of 72 genes and biomarkers related to tumors.
- Target Therapies and Immunotherapies (56 tested substances)
- The presence of Resistance Factor Markers.
- The presence of Heat Shock Proteins (HSP) which indicate a tumor’s resilience to radiotherapy and hyperthermia.
The results of this test allows for better targeted chemotherapy using only the most effective cancer-fighting compounds.
Sensivity to Natural Products
- Sensitivity Test for 53 Extracts and Natural Substances with anti-cancer activity
- Substance classes:
- Cytotoxic Agents
- Growth Factor Receptor Inhibitors
- Immune System Support Substances and Cell Apoptosis promoting substances
- Most natural substances currently used against cancer are tested, such as:
Agaricus Blazei, Alpha Lipoic Acid, Amygdalin (B17), Angiostop, Apigenin, Artesunate, Ascorbic Acid (Vitamin C), Boswellia, Avemar pulvis, Breastin, Butyric Acid, CoQ10, Cordyceps, C-statin, Curcumin, DDG, Frankincense, Fucoidan, GcMAF, Genistein, Indole-3-carbinol, Lycopene, Melatonin, Viscum (Helixor, Iscador), Naltrexone (LDN), Micellar D3, Onkobel Pro, Oxaloacetate, Paw-paw, Poly-MVA, Polyphoneole CA, Quercitina, Resveratrol, Orasal, Salvestrol, DCA – Sodium dichloroacetate, Artemisinin, Thymex, VascuStatin, Virxcan, Vitanox.
CTC (Circulating Tumor Cell) Detection
What the test does:
- Determines the origin of the CTC when the primary tumor is not known
- Provides prognosis information on each patient
- Immunophenotyping (method for characterization of the primary tumor when unknown)
- Determines the Presence and Concentration of Circulating Tumor Cells (CTC’s)
- Evaluates 21 tumor markers, both hematological CD 45(+) and non-hematological CD 45(-).
- Provides a Cancer Stem Cell Marker Assessment (CD133, Sox-2, OKT-4, Nanog, CD44)
Specifics of the exam
- A blood sample is collected (ideally in the morning) and stored in the cold, then sent (on the same day) to the laboratory
- Can be done by people who have not yet undergone chemotherapy or radiation
- In the case of people already undergoing chemo treatment, the blood collection should be performed at least 1 week after chemotherapy session
- Results are obtained within 7-15 days
- No need to be fasting
- The test must be scheduled at least 2 days in advance
- The harvest is made at the Naturena Clinic in Barcelos ( Portugal )